HIV-DRI

Providing Options – Empowering Practitioners

Drug resistance is the major contributing factor in the diminished efficacy of many therapeutic agents currently utilized throughout the world to treat HIV.
The HIV-DRI Roundtable Consensus ConferenceTM was a key component of the HIV-DRI Initiative developed in conjunction with the American Society for Microbiology (ASM).

This Case Study presents the scope of the effort and the nature of coordination involved with a professional medical society. The featured video clips provide examples of expert impact on different audience segments.

Raising Awareness of HIV Drug Resistance

Benefits of HIV-DRI to Clinicians and Patient